๐๐๐ข๐ ๐พ๐๐๐ฃ๐๐๐ง! ๐๐ฟ๐ผ ๐๐๐๐จ๐๐ฃ๐ ๐๐ช๐ฉ ๐ผ๐ฃ๐๐ข๐๐ก ๐๐๐จ๐ฉ๐๐ฃ๐ ๐๐ค๐ง ๐ผ๐ & ๐๐ช๐ข๐๐ฃ-๐๐๐ก๐๐ซ๐๐ฃ๐ฉ ๐ฟ๐ง๐ช๐ ๐ฟ๐๐ซ๐๐ก๐ค๐ฅ๐ข๐๐ฃ๐ฉ ๐
๐๐ช๐๐ ๐ฃ๐๐ฌ๐จ ๐๐ง๐ค๐ข ๐ฉ๐๐ ๐๐ฟ๐ผ! As of April 10, 2025, the U.S. Food and Drug Administration announced a groundbreaking plan to phase out mandatory animal testing for monoclonal antibodies and other drugs. This marks a monumental shift towards "more effective, human-relevant" methods like AI models and lab-grown human cell systems.
๐๐๐ฎ ๐ฉ๐๐๐จ ๐ข๐๐ฉ๐ฉ๐๐ง๐จ:
Faster & Cheaper Drug Development: This innovation-driven policy should significantly cut the time and cost of bringing new, life-saving drugs to market.
Massive ROI for AI Biotech: Our analysis suggests AI-developed therapeutics could boost returns on investment by 5x (to over 20% from ~4%), potentially reducing overall development costs by four-fold!
Unlocking Rare Disease Treatments: With reduced costs and accelerated timelines, AI could enable biotech companies to profitably address 75% of the rare disease patient population, dramatically expanding access to therapies where only ~5% currently exist.
Enhanced Patient Outcomes: More effective, accessible treatments mean improved quality of life and reduced healthcare costs.
This isn't just a regulatory change; it's the dawn of a new era for molecular medicine, powered by rapid advancements in AI, multiomics, and microphysiological systems. Companies already leveraging AI in drug discovery like AbSci, AbCellera, and Recursion Pharmaceuticals, as well as multiomics tool providers, stand to benefit immensely.
๐๐๐ ๐๐ฟ๐ผ'๐จ ๐๐ค๐ข๐ข๐๐ฉ๐ข๐๐ฃ๐ฉ ๐ฉ๐ค ๐๐ฃ๐ฃ๐ค๐ซ๐๐ฉ๐๐ค๐ฃ ๐ข๐๐๐ฃ๐จ ๐๐๐จ๐ฉ๐๐ง, ๐ข๐ค๐ง๐ ๐๐๐๐ช๐ง๐๐ฉ๐, ๐๐ฃ๐ ๐ข๐ค๐ง๐ ๐๐ค๐จ๐ฉ-๐๐๐๐๐๐ฉ๐๐ซ๐ ๐๐ง๐ช๐ ๐๐๐ซ๐๐ก๐ค๐ฅ๐ข๐๐ฃ๐ฉ ๐ฉ๐๐๐ฉ ๐๐๐ฃ๐๐๐๐ฉ๐จ ๐๐ซ๐๐ง๐ฎ๐ค๐ฃ๐ โ ๐๐ง๐ค๐ข ๐๐ฃ๐ฃ๐ค๐ซ๐๐ฉ๐ค๐ง๐จ ๐ฉ๐ค ๐ฅ๐๐ฉ๐๐๐ฃ๐ฉ๐จ ๐๐ฃ๐ ๐ฉ๐๐ ๐๐ฃ๐ฉ๐๐ง๐ ๐๐๐๐ก๐ฉ๐๐๐๐ง๐ ๐จ๐ฎ๐จ๐ฉ๐๐ข.
๐๐๐๐ ๐๐ค๐ง๐: europe.ark-funds.com/2025/05/from-animals-to-ai-the-fdas-new-policy-should-transform-the-drug-development-process/... Show More
Bestimmt!!Es ist sehr wahrscheinlich das es bald ne reverse split gebt,von betrรผger ist es eh nicht anderes zu erwarten,da sie bevor es extrem steigt reverse splits durchfรผhren!!Allen mittlerweile bekannt wie betrรผger es machen,nichts fremdes oder รผberaschend!Frage ist nur ob es bald kommt oder erst... Show More Translate
Finally animal testings coming to an end.๐... Show More
.
We use our own and third-party cookies on our websites to enhance your experience, analyze traffic, and for security and marketing. For more info, see our Cookie Policy or go to Manage Settings.
Privacy Preference Center
When you visit any website, it may store or retrieve information on your browser, mostly in the form of cookies. This information might be about you, your preferences or your device and is mostly used to make the site work as you expect it to. The information does not usually directly identify you, but it can give you a more personalized web experience. Because we respect your right to privacy, you can choose not to allow some types of cookies. Click on the different category headings to find out more and change our default settings. However, blocking some types of cookies may impact your experience of the site and the services we are able to offer.
More information
Manage Consent Preferences
Strictly Necessary Cookies
Always Active
These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms. You can set your browser to block or alert you about these cookies, but some parts of the site will not then work. These cookies do not store any personally identifiable information.
Performance Cookies
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Functional Cookies
These cookies enable the website to provide enhanced functionality and personalisation. They may be set by us or by third party providers whose services we have added to our pages. If you do not allow these cookies then some or all of these services may not function properly.
Targeting Cookies
These cookies may be set through our site by our advertising partners. They may be used by those companies to build a profile of your interests and show you relevant adverts on other sites. They do not store directly personal information, but are based on uniquely identifying your browser and internet device. If you do not allow these cookies, you will experience less targeted advertising.
